---
schema_version: "secwatch.filing_event.v1"
accession: "0000049071-24-000007"
form_type: "8-K"
ticker: "HUM"
cik: "0000049071"
company_name: "HUMANA INC"
filed_at: "2024-01-25T23:59:59+00:00"
generated_at: "2026-06-06T18:41:31.386591+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Humana posts Q4 GAAP loss of $4.42 per share; guides FY24 adj. EPS ~$16.00

## Summary
- Q4 GAAP loss per share $4.42; adjusted loss $0.11; FY23 GAAP EPS $20.00, adj. $26.09.
- Revenue $26.5B in Q4, up from $22.4B a year ago; benefits expense ratio rose to 90.7%.
- Higher Medicare Advantage inpatient utilization in Nov/Dec drove Q4 miss; costs assumed to persist in 2024.
- FY24 GAAP EPS guidance ~$14.87; adjusted ~$16.00, well below FY23 adjusted $26.09.
- Affirms ~100,000 individual Medicare Advantage membership growth (1.8%) for 2024.

## SEC filing metadata
- accession: 0000049071-24-000007
- form_type: 8-K
- ticker: HUM
- cik: 0000049071
- company_name: HUMANA INC
- filed_at: 2024-01-25T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/49071/000004907124000007/0000049071-24-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/49071/000004907124000007/hum-20240125.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000049071-24-000007
- JSON: https://secwatch.observer/filing/0000049071-24-000007.json
- Plain text: https://secwatch.observer/filing/0000049071-24-000007.txt

## Key facts
- Earnings Releases
  HUMANA INC reported the quarter ended December 31, 2023 results: EPS ($4.42).
  - Period: the quarter ended December 31, 2023
  - EPS: ($4.42)
  - Result: reported results
  source text: Humana Reports Fourth Quarter 2023 Financial Results; Provides Initial Full Year 2024 Financial Guidance • Reports 4Q23 loss per share of $4.42 on a GAAP basis, Adjusted loss per share of $0.11; reports FY 2023 earnings per share (EPS) of $20.00 on a GAAP basis, $26.09 on an Adjusted basis
  evidence_url: https://www.sec.gov/Archives/edgar/data/49071/000004907124000007/0000049071-24-000007-index.htm
- Earnings Releases
  HUMANA INC reported the year ending December 31, 2024 results: EPS approximately $14.87. Guidance initiated.
  - Period: the year ending December 31, 2024
  - EPS: approximately $14.87
  - Guidance: initiated
  - Result: guidance update
  source text: Humana provided its initial GAAP and Adjusted EPS guidance for the year ending December 31, 2024 (FY 2024) as detailed below. GAAP and Adjusted EPS results for FY 2023 are also shown for comparison. Diluted earnings per common share FY 2024 Guidance (c) FY 2023 (a) GAAP approximately $14.87 $20.00
  evidence_url: https://www.sec.gov/Archives/edgar/data/49071/000004907124000007/0000049071-24-000007-index.htm
- Earnings Releases
  HUMANA INC reported the year ended December 31, 2023 results: EPS $20.00.
  - Period: the year ended December 31, 2023
  - EPS: $20.00
  - Result: reported results
  source text: Humana Reports Fourth Quarter 2023 Financial Results; Provides Initial Full Year 2024 Financial Guidance • Reports 4Q23 loss per share of $4.42 on a GAAP basis, Adjusted loss per share of $0.11; reports FY 2023 earnings per share (EPS) of $20.00 on a GAAP basis, $26.09 on an Adjusted basis
  evidence_url: https://www.sec.gov/Archives/edgar/data/49071/000004907124000007/0000049071-24-000007-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.